XML 11 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Equity
3 Months Ended
Sep. 27, 2019
Share-based Payment Arrangement [Abstract]  
Equity
Equity
Stock Repurchase Program
In May 2018, our board of directors approved a repurchase program, which does not have an expiration date, for the repurchase of up to $7.5 million of our common stock.
The following table summarizes the repurchases of our common stock:
 
Three Months Ended
(In thousands, except share amounts)
September 27, 2019
 
September 28, 2018
Number of shares repurchased
55,452

 
23,579

Aggregate purchase price, including commissions
$
748

 
$
390



All repurchased shares were retired. As of September 27, 2019, $4.4 million remained available under our stock repurchase program.

Stock Incentive Programs
As of September 27, 2019, we had two stock incentive plans for our employees and nonemployee directors, the 2018 Incentive Plan and the 2007 Stock Equity Plan, as amended and restated effective November 13, 2015. During the three months ended September 27, 2019, we granted to our employees 63,030 restricted stock units, 51,706 performance restricted stock units and 126,118 options to purchase shares of our common stock.
Total compensation expense for share-based awards included in our unaudited condensed consolidated statements of operations was as follows:
 
Three Months Ended
(In thousands)
September 27,
2019
 
September 28,
2018
By Expense Category:
 
 
 
Cost of revenues
$
44

 
$
48

Research and development
27

 
36

Selling and administrative
336

 
352

Total share-based compensation expense
$
407

 
$
436

By Types of Award:
 
 
 
Options
$
110

 
$
38

Restricted and performance stock awards and units
297

 
398

Total share-based compensation expense
$
407

 
$
436


As of September 27, 2019, there was approximately $1.5 million of total unrecognized compensation expense related to nonvested stock options granted which are expected to be recognized over a weighted-average period of 2.6 years. As of September 27, 2019, there was $2.1 million of total unrecognized compensation expense related to nonvested stock awards which are expected to be recognized over a weighted-average period of 2.4 years.